Showing results (71-80 of 194) with videos related to

Sort By:
Pageof 20
Plos One|September 3, 2015
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized TrialsYunda Huang, Dean Follmann, Martha Nason, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Osteopenia in X-linked hyper-IgM syndrome reveals a regulatory role for CD40 ligand in osteoclastogenesisEduardo Lopez-Granados, Stephane T Temmerman, Lynne Wu, et al.
The Journal of Infectious Diseases|October 26, 2020
Clinical and Immunologic Predictors of Mycobacterium avium Complex Immune Reconstitution Inflammatory Syndrome in a Contemporary Cohort of Patients With Human Immunodeficiency VirusKimberly F Breglio, Caian L Vinhaes, María B Arriaga, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 30, 2006
Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene insertsRebecca L Sheets, Judith Stein, T Scott Manetz, et al.
Annals of Internal Medicine|October 22, 2020
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine TrialsDevan V Mehrotra, Holly E Janes, Thomas R Fleming, et al.
AIDS (London, England)|May 9, 2021
Broadly neutralizing antibody-mediated protection of macaques against repeated intravenous exposures to simian-human immunodeficiency virusDavid A Garber, Patricia Guenthner, James Mitchell, et al.
Plos One|March 31, 2010
Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferretSrinivas S Rao, Wing-Pui Kong, Chih-Jen Wei, et al.
Vaccine|December 3, 2014
Use of placebos in Phase 1 preventive HIV vaccine clinical trialsYunda Huang, Shelly T Karuna, Holly Janes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2019
Adaptive Viral Load Monitoring Frequency to Facilitate Differentiated Care: A Modeling Study From Rakai, UgandaVictor Ssempijja, Martha Nason, Gertrude Nakigozi, et al.
Journal of Virology|September 28, 2007
A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infectionChristof Geldmacher, Clive Gray, Martha Nason, et al.
Pageof 20